Company: APXIF
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065703
Chunk: 226

Company: APx Acquisition Corp. I
Filing Date: 2025-07-18
Form: F-4/A
Chunk 226
---
 last addresses as they appear on APx’s registration books; provided that holders will be able to exercise their APx Warrants prior to the Redemption Date and, at APx’s election, any such exercise may be required to be on a cashless basis. Any noticed mailed in the aforementioned manner shall be conclusively presumed to have been duly given whether or not the registered holder received such notice. 92 APx Warrants will become exercisable for Company Shares, which would increase the number of shares eligible for future resale in the public market and result in dilution to shareholders of APx. If the Business Combination is completed, outstanding APx Warrants to purchase an aggregate of 17,575,000 Company Shares will become exercisable in accordance with the terms of the SPAC Warrant Agreement governing those securities. The APx Warrants will become exercisable 30 days after the completion of the Business Combination. The exercise price of the APx Warrants will be $11.50 per share. To the extent such APx Warrants are exercised, additional Company Shares will be issued, which will result in dilution to the holders of Company Shares and increase the number of Company Shares eligible for resale in the public market. The dilution, as a percentage of outstanding Company Shares, caused by the exercise of the APx Warrants will increase if a large number of our shareholders elect to redeem their Public Shares in connection with the Business Combination. Further, the redemption of Public Shares without any accompanying redemption of Public Warrants will increase the dilutive effect of the exercise of APx Warrants. Sales of substantial numbers of such Company Shares in the public market or the fact that such APx Warrants may be exercised could adversely affect the market price of Company Shares. However, there is no guarantee that the APx Warrants will ever be in the money prior to their expiration, and as such, the warrants may expire worthless. Even if the Business Combination is consummated, APx Warrants may never be in the money, and they may expire worthless and the terms of the APx Warrants may be amended in a manner adverse to a holder if holders of at least 50% of the then -outstanding APx Warrants approve of such amendment. APx Warrants were issued in registered form under the SPAC Warrant Agreement. The SPAC Warrant Agreement provides that the terms of the warrants may be amended without the consent of any holder for the purpose of curing any ambiguity, including to confirm the provisions of the SPAC